Quantitative Assessments of Tumor Activity in a General Oncologic PET/CT Population: Which Metric Minimizes Tracer Uptake Time Dependence?
Where this comes from
- Record sourced from PubMed, PMID 39142828.
- Also identified by DOI 10.2967/jnumed.123.266469 and PMC identifier 11372261.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
In oncologic PET, the SUV and standardized uptake ratio (SUR) of a viable tumor generally increase during the postinjection period. In contrast, the net influx rate (<i>K<sub>i</sub></i> ), which is derived from dynamic PET data, should remain relatively constant. Uptake-time-corrected SUV (cSUV) and SUR (cSUR) have been proposed as uptake-time-independent, static alternatives to <i>K<sub>i</sub></i> Our primary aim was to quantify the intrascan repeatability of <i>K<sub>i</sub></i> , SUV, cSUV, SUR, and cSUR among malignant lesions on PET/CT. An exploratory aim was to assess the ability of cSUR to estimate <i>K<sub>i</sub></i> <b>Methods:</b> This prospective, single-center study enrolled adults undergoing standard-of-care oncologic PET/CT. SUV and <i>K<sub>i</sub></i> images were reconstructed from dynamic PET data obtained before (∼35-50 min after injection) and after (∼75-90 min after injection) standard-of-care imaging. Tumors were manually segmented. Quantitative metrics were extracted. cSUVs and cSURs were calculated for a 60-min postinjection reference uptake time. The magnitude of the intrascan test-retest percent change (test-retest |%Δ|) was calculated. Coefficients of determination (<i>R</i> <sup>2</sup>) and intraclass correlation coefficients (ICC) were also computed. Differences between metrics were assessed via the Wilcoxon signed-rank test (α, 0.05). <b>Results:</b> This study enrolled 78 subjects; 41 subjects (mean age, 63.8 y; 24 men) with 116 lesions were analyzed. For both tracers, SUV<sub>max</sub> and maximum SUR (SUR<sub>max</sub>) had large early-to-late increases (i.e., poor intrascan repeatability). Among [<sup>18</sup>F]FDG-avid lesions (<i>n</i> = 93), there were no differences in intrascan repeatability (median test-retest |%Δ|; ICC) between the maximum <i>K<sub>i</sub></i> (<i>K<sub>i</sub></i> <sub>,max</sub>) (13%; 0.97) and either the maximum cSUV (cSUV<sub>max</sub>) (12%, <i>P</i> = 0.90; 0.96) or the maximum cSUR (cSUR<sub>max</sub>) (13%, <i>P</i> = 0.67; 0.94). For DOTATATE-avid lesions (<i>n</i> = 23), there were no differences in intrascan repeatability between the <i>K<sub>i</sub></i> <sub>,max</sub> (11%; 0.98) and either the cSUV<sub>max</sub> (13%, <i>P</i> = 0.41; 0.98) or the cSUR<sub>max</sub> (11%, <i>P</i> = 0.08; 0.94). The SUV<sub>max</sub>, cSUV<sub>max</sub>, SUR<sub>max</sub>, and cSUR<sub>max</sub> were all strongly correlated with the <i>K<sub>i</sub></i> <sub>,max</sub> for both [<sup>18</sup>F]FDG (<i>R</i> <sup>2</sup>, 0.81-0.92) and DOTATATE (<i>R</i> <sup>2</sup>, 0.88-0.96), but the cSUR<sub>max</sub> provided the best agreement with the <i>K<sub>i</sub></i> <sub>,max</sub> across early-to-late time points for [<sup>18</sup>F]FDG (ICC, 0.69-0.75) and DOTATATE (ICC, 0.90-0.91). <b>Conclusion:</b> <i>K<sub>i</sub></i> <sub>,max</sub>, cSUV<sub>max</sub>, and cSUR<sub>max</sub> had low uptake time dependence compared with SUV<sub>max</sub> and SUR<sub>max</sub> The <i>K<sub>i</sub></i> <sub>,max</sub> can be predicted from cSUR<sub>max</sub>.
Medical subject headings
- Positron Emission Tomography Computed Tomography
- Neoplasms